Australia markets closed

PROCEPT BioRobotics Corporation (PRCT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
62.65-0.35 (-0.56%)
At close: 04:00PM EDT
61.99 -0.66 (-1.05%)
After hours: 07:43PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.22B
Enterprise value 3.08B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)19.53
Price/book (mrq)12.20
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.95
52-week change 392.00%
S&P500 52-week change 326.27%
52-week high 365.00
52-week low 324.83
50-day moving average 351.52
200-day moving average 340.88

Share statistics

Avg vol (3-month) 3569.4k
Avg vol (10-day) 3897.53k
Shares outstanding 551.42M
Implied shares outstanding 651.42M
Float 846.13M
% held by insiders 14.05%
% held by institutions 187.56%
Shares short (30 Apr 2024) 45.66M
Short ratio (30 Apr 2024) 410.53
Short % of float (30 Apr 2024) 415.16%
Short % of shares outstanding (30 Apr 2024) 411.00%
Shares short (prior month 28 Mar 2024) 44.65M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -66.12%
Operating margin (ttm)-62.08%

Management effectiveness

Return on assets (ttm)-20.31%
Return on equity (ttm)-47.29%

Income statement

Revenue (ttm)156.33M
Revenue per share (ttm)3.21
Quarterly revenue growth (yoy)82.50%
Gross profit (ttm)N/A
EBITDA -104.24M
Net income avi to common (ttm)-103.37M
Diluted EPS (ttm)-2.12
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)225.58M
Total cash per share (mrq)4.39
Total debt (mrq)83.3M
Total debt/equity (mrq)31.55%
Current ratio (mrq)8.52
Book value per share (mrq)5.14

Cash flow statement

Operating cash flow (ttm)-104.36M
Levered free cash flow (ttm)-99.36M